Fresenius Kabi Oncology Ltd

  • Market Cap Cr.
  • Current Price 132
  • High & Low
  • Stock PE
  • Book Value 25.7
  • Dividend 0.00 %
  • ROCE 8.61 %
  • ROE 11.2 %
  • Face Value 1.00

About Fresenius Kabi Oncology Ltd

Fresenius Kabi Oncology Ltd is a prominent player in the industry, boasting a substantial market cap of ₹ Crore. The current share price stands at ₹ 132, with the stock having fluctuated between over the past year. The company's stock is priced at a P/E ratio of , indicating investor expectations of future growth.

Fresenius Kabi Oncology Ltd's book value per share is ₹ 25.7, reflecting the company's net asset value. Despite a modest dividend yield of 0.00%, Fresenius Kabi Oncology Ltd demonstrates strong profitability metrics with a Return on Capital Employed (ROCE) of 8.61% and a Return on Equity (ROE) of 11.2%. The face value of each share is ₹ 1.00, which is the nominal value of the stock.